Niemann-pick Disease Type
📧 Sign up to get email alerts when something new happens for Niemann-pick Disease Type.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2023-02-08EMA Application withdrawn: Miplyffa (arimoclomol citrate) — Orphazyme A/S
The EMA has withdrawn the application for Miplyffa (arimoclomol citrate) by Orphazyme A/S for Niemann-Pick Disease Type C.